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Virus detection and taxonomic identification of sero-
types, strains, or genotypes provide important infor-
mation relevant for diagnosis, and for the epidemio-
logical characterization and tracking of new strains in
an endemic region. In the specific case of dengue
virus, rapid serotype identification can also be useful
in the treatment of secondary infections that may
cause the more severe dengue hemorrhagic fever and
dengue shock syndrome. In this work, dengue virus
was used as a model to test a new approach of com-
bining broadly sensitive RT-PCR amplification of
nearly any virus strain with subsequent serotype- and
finer-level identification by mass spectrometry. PCR
primers were appended with promoter sequences,
such that the resulting PCR products could be tran-
scribed into RNA. RNA fragments generated by
guanosine-specific RNase T1 digestion were analyzed
bymatrix-assisted laser desorption/ionization-time of
flight mass spectrometry. Viral serotypes were iden-
tified by comparing the pattern of observed fragment
masses to a mass database. The database was created
by computationally fragmenting 2517 dengue strains
after each guanosine residue using the same primers.
Computationally, all 2517 strains in themass database
were correctly identified at the serotype level from
the predicted PCR product. The methodology was suc-
cessfully demonstrated experimentally by identifying
the serotypes of eight test strains using mosquito cell
cultures infected with strains of all four serotypes and
with full-length cDNA clones. (J Mol Diagn 2012, 14:402-
407; http://dx.doi.org/10.1016/j.jmoldx.2012.02.006)
402It is often desirable that a pathogen diagnostic method
provide some degree of taxonomic information about the
particular genotype that has been detected, both for sur-
veillance and in some cases for prognostic uses. Taxo-
nomic classification of a particular isolate without re-
course to sequencing, culture, or other time-consuming
methods is especially desirable. Using dengue virus as a
model system, we demonstrate the utility of combining
broadly sensitive RT-PCR amplification of sequences
from nearly any strain of the target virus with rapid mass
spectrometric characterization of the individual isolates.
Dengue virus is the causative agent of dengue fever,
dengue hemorrhagic fever, and dengue shock syndrome
with an estimated 50 million infections and 12,500 fatali-
ties worldwide each year.1,2 The virus is reported in an
increasing number of countries, including, most recently,
locally acquired infections in the United States of Amer-
ica.3 The virus occurs in four serotypes (DENV-1 to -4)
with more than 2700 different strains currently reported
[National Center for Biotechnology Information (NCBI),
http://www.ncbi.nlm.nih.gov/genome/10308, last accessed
April 30, 2011]. Since a second dengue virus infection
by a different serotype is more likely to lead to hemor-
rhagic fever or dengue shock syndrome, the rapid iden-
tification of the serotype is therefore of great interest in
these cases. Current methods of detection and typing are
primarily serological or rely on time-consuming virus cul-
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based technologies.4–12
We have recently developed a new approach to rapid
identification of pathogens by combining PCR amplifica-
tion and matrix-assisted laser desorption/ionization-time
of flight (MALDI-TOF) mass spectrometry of base-spe-
cific ribonuclease digestion fragments of RNA tran-
scribed from the PCR products.13–16 In this approach,
PCR primers are appended with an RNA polymerase
promoter sequence so that the amplification products
can be readily transcribed into RNA. The RNA is then
digested using RNase T1, a highly guanosine-specific
endoribonuclease, and the resulting fragments are ana-
lyzed by MALDI-TOF. The mass spectrum of the digest is
then compared to an existing database of digestion pat-
terns for pathogen genes, eg, bacterial genomic 16S
rRNA13–15 or viral genomic sequences.16 We also re-
cently reported a single set of 10 PCR primers designed
for the specific and sensitive detection of nearly all (95%)
of 1688 then-sequenced dengue virus strains of all four
serotypes.17 These new primers are highly specific for
dengue virus when tested in the presence of a vast ex-
cess of human DNA or DNA of the carrier mosquito,
Aedes aegypti. Moreover, they can be used directly for
reverse transcription of dengue viral RNA, bypassing the
need for initial synthesis of a cDNA template with a dif-
ferent set of primers. Computational tests further predict
that the primers are highly specific for dengue virus when
tested against other non-dengue flaviviruses. Addition-
ally, sequence variations in dengue virus due to wide
geographical distribution did not significantly degrade
the predicted performance of the primers, supporting the
potential global use of these primers. In the present work,
we combine this near-universal amplification capability
with mass spectrometric identification to enable rapid
detection, serotyping, and strain identification of nearly
all known dengue strains. We report the results of simu-
lation of PCR and subsequent typing of dengue strains.
We also demonstrate the methodology experimentally
using mosquito cell cultures infected with DENV-1 (Piura,
Peru), DENV-2 (New Guinea C), DENV-3 (Asuncion, Par-
aguay), and DENV-4 (Dominica, West Indies) strains, and
full-length cDNA clones.
Table 1. Primer Sequences Used for Dengue Virus Detection
Primer pair Dengue serotype
1G1P1 DENV-1
1G1P1 DENV-2
2G2P5 DENV-2
1G3P6 DENV-1
1G4P217 DENV-3
1G5P30 DENV-4
All forward (F) and reverse (R) primer sequences were appended (b
sequence, respectively. For antisense strand mass patterns, reverse primers were
sequence (not shown).Materials and Methods
Predictive Mass Spectral Database
We created a database using publicly available se-
quence information on dengue virus strains. On April 14,
2011, a search of the NCBI nucleotide database (Gen-
Bank) for “dengue[title] and viruses[organism]” resulted
in 9566 hits. Among the dengue sequences, we identified
2718 as serotype 1, 3119 as serotype 2, 2671 as sero-
type 3, and 855 as serotype 4, using sequence name
identifiers. The serotypes of the remaining 203 se-
quences could not be determined because of ambiguity
in sequence names and sequence information. Of the
9566 sequences, 2736 sequences were identified as
complete genomes and were recognized as individual
strains. To create virtual PCR amplicons using our primer
cocktail (Table 1), all possible combinations of forward
and reverse primers were queried against genomic
sense and antisense strands in these 2736 strains. Ad-
ditionally, mismatch-tolerant searches were conducted
using custom-coded fast Fourier transform–based corre-
lation functions. This approach is similar to, but distinct
from that described previously by other groups18,19 in
that an initial transform of genetic sequence information
to complex numbers (eg, [A,T,G,C]↔ [1,1,i,i]) allows
the use of well-established Fourier transform–based cor-
relation functions for quickly searching for primer se-
quences while allowing for any specified number of mis-
matches. By allowing for up to four mismatches in each
primer (mismatches positioned randomly in the primer
sequence), we simulated less-stringent experimental
conditions. We cataloged all potential amplicons in a
database for subsequent in silico base-specific cleavage
by RNase T1 (simulated cleavage after guanosine resi-
dues and prediction of mass fragment patterns). The
entire data set is organized and curated using a MySQL
database running under Linux. Spectral matching and
database updating procedures were implemented in the
Perl scripting language. Results are formatted into HTML
and presented to the user in tabular format in a standard
web browser. This database structure allows seamless
Primer sequences
=-TAATACGACTCACTATAGGCAAACCATGGAAGCTGTACG-3=
=-CTATATACTATATATATACTTCTGTGCCTGGAATGAT-3=
=-TAATACGACTCACTATAGGCAAACCATGGAAGCTGTACG-3=
=-CTATATACTATATATATACTTCTGTGCCTGGAATGATGCT-3=
=-TAATACGACTCACTATAGGGAGTGGAGTGGAAGGAGAAGGG-3=
=-CTATATACTATATATATACCCTCTTGGTGTTGGTCTTTGC-3=
=-TAATACGACTCACTATAGGCAGACTAGTGGTTAGAGGAGA-3=
=-CTATATACTATATATATACGGAATGATGCTGTAGAGACA-3=
=-TAATACGACTCACTATAGGATATGCTGAAACGCGTGAG-3=
=-CTATATACTATATATATACCATCATGAGACAGAGCGAT-3=
=-TAATACGACTCACTATAGGTTCCAACAAGCAGAACAACAT-3=
=-CTATATACTATATATATACGCTACAGGCAGCACGGTTT-3=
either a T7 promoter sequence or an internal standard mass calibrationF: 5
R: 5
F: 5
R: 5
F: 5
R: 5
F: 5
R: 5
F: 5
R: 5
F: 5
R: 5
old) to
appended to the T7 promoter, and forward primers to a mass calibration
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quence information becomes available.
PCR Amplification and Mass Spectrometry of
PCR Products
In a typical experiment, each dengue strain was tested
with the primer set with a T7 promoter sequence ap-
pended to either forward or reverse primers (Table 1).
The PCR products were purified using QIAquick PCR
Purification Kit (Qiagen, Valencia, CA). DNA was then
transcribed into RNA and enzymatically cleaved with
RNaseT1, followed by acquisition of the corresponding
MALDI spectra. We purified PCR products for use as
templates for in vitro transcription using the T7-Flash kit
(Epicenter, Madison, WI). Amino-allyl UTP was substi-
tuted for UTP in the reaction to give improved distinction
of U/C-containing mass fragments.15 The transcripts
were completely digested by RNase T1 at 37°C for 5
minutes and then placed on ice for MALDI preparation
using ZipTip reverse-phase pipette tips (Millipore, Bil-
lerica, MA). Mass spectra of the digests were acquired in
linear, negative ion mode on a Voyager DE-STR MALDI-
TOF instrument (Applied Biosystems, Carlsbad, CA). We
then compared the observed masses to the database
above using a spectral scoring function based on inner
products as described previously.13–16
Primers (Table 1) were tested against dengue virus
cDNAs and viral RNA. Full-length cDNA clones of
DENV-1 West Pacific (GenBank accession: U88535;
NCBI GI: 1854036), DENV-2 New Guinea C (M29095; GI:
323447), DENV-3 (FJ639719; GI: 221071269), and
DENV-4 (GU289913; GI: 280987259) in the yeast–Esch-
erichia coli shuttle vector pRS424 were used. Each reac-
tion contained 100 pg of cDNA and 100 nmol/L of each
primer. Controls omitting the DNA template were in-
cluded. Brilliant II SYBR Green Q-PCR Master Mix (Agi-
lent Technologies, Valencia, CA) was used to perform
real-time PCR. Thermocycling was performed for 35 cy-
cles, with annealing at 60°C (1 minute) and extension at
72°C (1 minute).
Total RNA from C6/36 mosquito cell cultures infected
with dengue virus; DENV-1 (Piura, Peru), DENV-2 (New
Guinea C) (GenBank accession: M29005; NCBI GI:
323447), DENV-3 (Asuncion, Paraguay), and DENV-4
(Dominica, West Indies) was tested. The DENV-1,
DENV-3, and DENV-4 strains do not have NCBI identifiers
because they are not yet sequenced. We used primer
cocktails (100 nmol/L per primer; 10 primers) for both the
reverse transcription and amplification steps. Brilliant II
SYBR Green Q-RTPCR Master Mix (Agilent Technolo-
gies) was used to perform real-time RT-PCR. The reverse
transcription step was performed according to the man-
ufacturer’s protocol (50°C, 30 minutes). Thermocycling
was performed for 35 cycles, with annealing at 60°C (1
minute) and extension at 72°C (1 minute). Controls omit-
ting RNA template and reverse transcriptase were in-
cluded to rule out primer–dimer formation and amplifica-
tion, respectively, due to the presence of any DNA in the
total RNA sample. We also tested total RNA from normaluninfected C6/36 cells as a negative control. The
Mx3005P QPCR system (Agilent Technologies) was used
for thermocycling and real-time monitoring. For demon-
stration of serotype identification, only the sense strand
was transcribed in case of the virus RNA samples.
Simulated Serotyping of Dengue Strains
Using the same set of 10 primers (Table 1) that were used
to compile the database, we exhaustively simulated the
recovered serotype for each entry in our database. Spe-
cifically, we predicted the expected set of RNase T1
fragments and compared it with the predicted mass pat-
terns from the dengue mass spectral database. The final
calculated mass spectral coincidence was normalized by
the overall highest value, generating an “identification
rank” value. The highest rank of 1 was therefore the best
match or serotype ID of a test strain. The trivial result, that
is, the recovered serotype of the test strain itself, was
ignored. As the strains of one serotype are more closely
related to each other than to other serotypes, the predic-
tive mass database is useful in the identification of the
serotype of a test strain.16 The results are expressed as
the percentage of tested strains matching their respec-
tive serotype with a rank of 1 (Table 2).
Results
In Silico PCR Detection, Mass-Spectrometric
Database Prediction, and Serotyping
Using the primer set and considering mass patterns from
amplicons of both sense and antisense strands of the
dengue virus genome, we predicted the detection of
2517 of 2736 dengue strains. Following simulated RNase
T1 digestion, we predicted 14,084 unique mass patterns
(4146 DENV-1, 6055 DENV-2, 3573 DENV-3, and 310
DENV-4) to form the mass spectrometric database. The
number of unique patterns is higher than the number of
unique strains because each strain can have multiple
patterns obtained through the use of different primer
pairs. The recovered serotype for each entry in our da-
tabase of 2517 strains was determined by simulated
identification where the trivial result (recovered serotype
for the test strain) was ignored. All mass patterns ob-
Table 2. Recovery of Serotype by Simulated Identification of
2517 Dengue Strains in the Mass Spectrometric
Database
Serotype of in silico
sample (no. of
tested strains)
Number of test strains matching a
serotype (%)
DENV-1 DENV-2 DENV-3 DENV-4
DENV-1 (982) 99.98 0.02 0 0
DENV-2 (856) 0.05 99.95 0 0
DENV-3 (597) 0 0 100 0
DENV-4 (82) 0 0 0 100
Numbers are percentage of tested strains matching a serotype with
rank of 1.tained were considered for comparison with the data-
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identified correctly (Table 2).
Experimental Demonstration of PCR Detection
and Mass-Spectrometric Serotyping
In a typical experiment, each dengue strain was ampli-
fied with the primer set shown in Table 1. PCR products
were purified and DNA was transcribed into RNA and
enzymatically cleaved with RNaseT1 followed by acqui-
sition of the corresponding MALDI-TOF spectrum. The
observed PCR product fragment masses of all four sero-
types were then compared with the predicted masses for
2517 dengue virus strains in the database (Figure 1). The
matches are listed in order from highest to lowest match,
which was based on the identification rank or the normal-
ized spectral coincidence analysis score. The product of
coincidence scores of mass spectra of both sense and
antisense strands was used to determine the final out-
come and normalized by the highest value.
Comparing mass patterns of the sense and antisense
strands of the PCR amplicons of DENV cDNA clones
against the predicted database (summarized in Tables 3
and 4, detailed in Supplemental Tables S1–S4 available
at http://jmd.amjpathol.org), the top hits matched the
tested serotype in every case. The test strains of DENV-1,
DENV-2, and DENV-4 were found among the highest
ranking strains. However, the DENV-3 test strain ranked
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Figure 1. Mass spectra of fragments generated from PCR products of all four
serotypes (DENV-1 to -4) using the primer cocktail. Vertical axis is a normal-
ized representation of relative peak intensity of all serotypes.21st among 498 DENV-3 strains considered. The lowestrank number and the total number of strains can differ
because more than one strain can have the same rank
based on mass pattern.
Comparing mass patterns of sense strands for PCR
amplicons of DENV RNA, the top hits matched the test
serotype in every case (Table 4, detailed in Supplemental
Tables S5–S8 available at http://jmd.amjpathol.org). For
DENV-1 (Piura, Peru), the 200 highest ranking strains
belonged to serotype 1. For DENV-2, all 505 strains
matched to serotype 2, and the test strain (GI: 323447)
was found among the highest ranked strains. For
DENV-3, all 500 strains belonged to serotype 3. For
DENV-4, the top 7 identified strains belonged to serotype
4, and the remaining to either DENV-3 or DENV-4. We
found that there are similarities in mass patterns between
DENV-3 and -4, which are not directly discernible from
sequence alignment. (Supplemental Table S9, available
at http://jmd.amjpathol.org, gives some of the details of
the underlying database in terms of the number of
masses and unique patterns for each serotype.) The sim-
ilarity of DENV-4 strains implies that when one of the
DENV-4 mass patterns matches that of DENV-3, most
other DENV-4 mass patterns also show similar results.
Fortunately, such problems can be predicted by simula-
tion and can be resolved by analysis of the antisense
strand or additional sequence regions.
Discussion
We have shown that the combination of human-blind
primer-cocktail PCR and typing by relatively inexpensive
MALDI-TOF mass spectrometry enables broadly sensi-
tive detection and serotype identification of dengue virus.
We demonstrated this methodology by simulation of typ-
ing of dengue strains in silico, and subsequent experi-
ments with both cDNA clones and dengue virus genomic
RNA. Having just one set of primers for the identification
of all dengue serotypes and strains constitutes a signifi-
cant advantage as any test sample can be identified for
the presence of dengue virus rapidly without any prior
knowledge about its identity. Comparative analysis of the
mass spectrum profile can particularly aid in the identifi-
cation of a previously unidentified or new isolate. Stan-
dard mass spectra may be used as a reference to identify
unknown or ambiguous test samples.
As demonstrated by the correct identification of three
of the four tested dengue cDNA strains (Tables 3 and 4)
using PCR amplicons, strain-level resolution may be
achieved using the mass spectra. Strain identification
may be informative in tracking virus spread for epidemi-
ological characterization, but may not be necessary in
curbing a potential outbreak or even for treatment. Iden-
tification of both virus and serotype, however, is neces-
sary and may help control hemorrhagic fever spread and
fatality by timely identification. Serotypes of all 2517
strains were predicted to be identified correctly, when
each strain was tested against the database and the
test-strain was ignored from the recovered matches.
The current primer set only examines 2% to 4% of the
dengue genome. To further improve identification, a
all strain
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primers spanning a larger genomic region using more
primer pairs, or using more than one amplicon. Ibis Bio-
sciences’ T-5000 Biosensor (Abbott Laboratories, Abbott
Park, IL) also utilizes a “universal” PCR approach cou-
pled with subsequent mass spectrometric characteriza-
tion of the resulting whole amplicons.20,21 Although our
approach using RNase T1 fragmentation requires addi-
tional transcription and cleavage reactions, such frag-
mentation allows for less expensive, lower-resolution
MALDI instrumentation to be used.
In recent years, several studies have suggested sero-
type-specific disease behavior.22–24 Specifically, the carrier
mosquito A. aegypti has been reported to be more suscep-
tible to infection by DENV-2 serotype,25 which may lead to
greater incidence of infection by DENV-2. Rapid and quan-
Table 3. Mass Spectral Typing of DENV cDNA Clones with Prim
Overall rank
Normalized
score
DENV-1 WP (GI: 1854036)
1 1 Dengue vir
1 1 Dengue vir
108† 0.73 Dengue vir
complete
DENV-2 NGC (GI: 323447)
1 1 Dengue vir
complete
1 1 DEN2CGA
virus 2
390‡ 0.53 Dengue vir
dengue v
DENV-3 (GI: 221071269)
1 1 Dengue vir
genome/
21 0.95 Dengue vir
complete
498§ 0.5 DENCME d
complete
DENV-4 (GI: 280987259)
1 1 Dengue vir
1 1 Dengue vir
76¶ 0.27 Dengue vir
*Test strain in bold.
†Lowest ranking DENV-1 strain; all 108 DENV-1 strains ranked above
‡Lowest ranking DENV-2 strain; all 397 DENV-2 strains ranked above
§Lowest ranking DENV-3 strain; all 500 DENV-3 strains ranked above
¶Lowest ranking DENV-4 strain; all 77 DENV-4 strains ranked above
cds, coding sequence.
Table 4. Experimental Serotype Identification of All Dengue Viru
Tested strain (NCBI Accession/GI) Normalized score
Virus cDNA
DENV-1 WP (U88535/1854036) 1
DENV-2 NGC (M29095/323447) 1
DENV-3 (FJ639719/221071269) 1
DENV-4 (GU289913/280987259) 1
Virus RNA
DENV-1 (Piura, Peru) NA
DENV-2 NGC (M29095/323447) 1
DENV-3 (Asuncion, Paraguay) NA
DENV-4 (Dominica, West Indies) NAMass spectral score normalized for each serotype is listed with observed se
NA, not applicable, only the serotype can be identified when sequence infortitative typing may help in early detection of DENV-2 for
aggressive prevention of a potential outbreak. Co-circula-
tion of two serotypes in a region is also thought to promote
occurrence of dengue hemorrhagic fever,26 associated
with secondary infections. Serotype identification in such
regions may help reduce secondary infection. Although
there is no specific drug for treatment of dengue infection,
several candidates have been reported.27–30 Recently, one
drug candidate was reported to inhibit only DENV-1, -2, and
-3 serotypes29 (possibly because DENV-4 is most divergent
in E protein sequence31,32 where the inhibitor is thought to
bind). If eventually dengue serotype-specific drugs are de-
veloped, then serotyping would be of essence to determine
the course of treatment.
Finally, in the case of a highly mutable RNA virus such
as dengue (in which the mutation rate can be as high as
ktail by Overall Score
Identified serotype NCBI GI*
olate DENV-1/PH/BID-V2940/2004 259496234
lone WestPac 1854036
1 recombinant clone rDEN1mutF,
e
22901063
olate DENV-2/CO/BID-V1598/1944,
e
209976573
e virus type 2 complete genome/dengue 323447
2 strain ThNH54/93, complete genome/ 6841593
3 strain C0360/94, complete
d/plasma from patient DF
60326968
olate DENV-3/KH/BID-V2071/2000,
e
221071269
type 3 virus complete genome RNA,
engue virus 3
323468
rain 341750, complete genome/Colombia 280987259
4 strain 814669, complete genome 12659201
4 strain ThD4_0476_97, complete genome 53653742
ins of any other serotype.
ins of any other serotype.
ins of any other serotype.
s of any other serotype.
A and RNA Test Strains
Correct serotype ID Correct strain ID with top score
Yes Yes
Yes Yes
Yes No; Score: 0.95
Yes Yes
Yes NA
Yes Yes
Yes NA
Yes NAer Coc
us 1, is
us 1, c
us type
genom
us 2 is
genom
dengu
us type
irus 2
us type
Thailan
us 3 is
genom
engue
cds/d
us 4 st
us type
us type
all stra
all stra
all stras cDNrotype ID.
mation is not available.
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tive mass database must be continuously updated using
current sequence information. Our method and support-
ing database can be easily updated, and are thus well
suited to address this issue. The combination of cocktail-
PCR strategy and subsequent mass spectral analysis of
the amplicons also may be useful for the diagnosis of
other pathogens16 for which PCR detection methods are
already well established.
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